Pegylated Liposomal Doxorubicin with Vinorelbine in Metastatic Breast Carcinoma

Oncology ◽  
2002 ◽  
Vol 63 (1) ◽  
pp. 23-30 ◽  
Author(s):  
Vittorio Gebbia ◽  
Gaetano Mauceri ◽  
Giuseppina Fallica ◽  
Nicolò Borsellino ◽  
Maria Lina Tirrito ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Liposomal Doxorubicin ◽  
Metastatic Breast ◽  
Pegylated Liposomal Doxorubicin ◽  
Metastatic Breast Carcinoma

scholarly journals Weekly pegylated liposomal doxorubicin and paclitaxel in patients with metastatic breast carcinoma: A phase II study

2010 ◽  
Vol 1 (4) ◽  
pp. 749-753 ◽  
Author(s):  
VITA LEONARDI ◽  
VALENTINA PALMISANO ◽  
ALESSIO PEPE ◽  
ANTONELLA USSET ◽  
GIOVANNA MANUGUERRA ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Phase Ii ◽  
Liposomal Doxorubicin ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Pegylated Liposomal Doxorubicin ◽  
Metastatic Breast Carcinoma

scholarly journals Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma

Cancer ◽  
2000 ◽  
Vol 89 (5) ◽  
pp. 1037-1047 ◽  
Author(s):  
Olga Lyass ◽  
Beatrice Uziely ◽  
Rami Ben-Yosef ◽  
Dinah Tzemach ◽  
Norman I. Heshing ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Liposomal Doxorubicin ◽  
Metastatic Breast ◽  
Pegylated Liposomal Doxorubicin ◽  
Metastatic Breast Carcinoma

Gemcitabine (GEM) and liposomal doxorubicin (PLD) in recurrent/metastatic breast carcinoma: A phase II study

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 790-790 ◽  
Author(s):  
V. Adamo ◽  
G. Ferrandina ◽  
M. Spada ◽  
F. Ferrau’ ◽  
G. Condemi ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Phase Ii ◽  
Liposomal Doxorubicin ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Metastatic Breast Carcinoma
Sign in / Sign up

Export Citation Format

Share Document